๐ฐ Cellular Immune News
Page 2 - Cellular Immune News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cellular Immune. Real-time updates on events, politics, business and more.
July 16, 2022
Alzheimer's disease is a progressive neurological disorder that causes brain atrophy and causes brain cells to die.
July 13, 2022
Worldwide Clinical Trials has entered a strategic collaboration with Invitae to expedite clinical trials for rare disease patients.
June 28, 2022
Several companies have announced poor results from clinical trials for Alzheimerโs disease therapies this month.
June 10, 2022
With a number of Covid-19 clinical trials in Europe now considered as research waste, sponsors should prepare for more guidelines.
May 25, 2022
Aerie Pharmaceuticals has announced the dosing of the first participant in the Phase III clinical trial of AR-15512 solution to treat DED.
May 17, 2022
Emmes has announced plans to offer data, statistical analysis and project management support for Modernaโs Covid-19 vaccine trial in Africa.
May 13, 2022
University of California researchers have developed an app that uses a near-infrared camera to check for neurological disease.
May 5, 2022
Catalyst Clinical Research acquired Aptus Clinical for expediting expansion to Europe, widening client services and improving patient impact.
April 28, 2022
Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.
April 28, 2022
The UT Health San Antonio has received a four-year award of $2.4m from the NIH to study usage of antibiotics for periodontal disease.